In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aloperidol Drug Master File in Korea (Aloperidol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aloperidol. The MFDS reviews the Aloperidol KDMF as part of the drug registration process and uses the information provided in the Aloperidol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aloperidol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aloperidol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aloperidol suppliers with KDMF on PharmaCompass.